Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Medicinal Chemistry

• Publication date

  2015-08-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/0929867322666150904111214PMID 26337105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid.

  2015cited by this paper
• Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.

  2015cited by this paper
• Investigational Lymphatic Imaging at the Bedside in a Pediatric Postoperative Chylothorax Patient

  2014cited by this paper
• An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease

  2014cited by this paper
• Chemoenzymatic Strategy for the Synthesis of Site-Specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging

  2014cited by this paper
• Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody

  2014cited by this paper
• Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

  2014cited by this paper
• Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation

  2014cited by this paper
• Far-red and near infrared BODIPY dyes: synthesis and applications for fluorescent pH probes and bio-imaging.

  2014cited by this paper
• DMAP-BODIPY alkynes: a convenient tool for labeling biomolecules for bimodal PET-optical imaging.

  2014cited by this paper
• In Vivo Imaging of GLP-1R with a Targeted Bimodal PET/Fluorescence Imaging Agent

  2014cited by this paper
• Dual labeling of lipopolysaccharides for SPECT-CT imaging and fluorescence microscopy.

  2014cited by this paper
• Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts

  2014cited by this paper
• Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue.

  2014cited by this paper
• Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer

  2013cited by this paper
• Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes.

  2013cited by this paper
• Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience

  2013cited by this paper
• Site-specific antibody drug conjugates for cancer therapy

  2013cited by this paper
• Multimodal chelation platform for near-infrared fluorescence/nuclear imaging.

  2013cited by this paper
• Near‐infrared fluorescence‐guided resection of colorectal liver metastases

  2013cited by this paper
• Diels–Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody

  2013cited by this paper
• Comparing the Hybrid Fluorescent–Radioactive Tracer Indocyanine Green–99mTc-Nanocolloid with 99mTc-Nanocolloid for Sentinel Node Identification: A Validation Study Using Lymphoscintigraphy and SPECT/CT

  2012cited by this paper
• Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging.

  2012cited by this paper
• Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.

  2012cited by this paper
• Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

  2012cited by this paper
• Comparison of mAbs Targeting Epithelial Cell Adhesion Molecule for the Detection of Prostate Cancer Lymph Node Metastases with Multimodal Contrast Agents: Quantitative Small-Animal PET/CT and NIRF

  2012cited by this paper
• Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe

  2012cited by this paper
• 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer.

  2012cited by this paper
• Design of peptide imaging agents for whole-body and intraoperative molecular imaging.

  2012cited by this paper
• ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging

  2012cited by this paper
• Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET

  2012cited by this paper
• Translation of near-infrared fluorescence imaging technologies: emerging clinical applications.

  2012cited by this paper
• 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer

  2012cited by this paper
• A review of NIR dyes in cancer targeting and imaging.

  2011cited by this paper
• Synthesis and in vivo fate of zwitterionic near-infrared fluorophores.

  2011cited by this paper
• Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.

  2011cited by this paper
• Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

  2011cited by this paper
• Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis

  2011cited by this paper
• Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry

  2011cited by this paper
• Dual-Labeling Strategies for Nuclear and Fluorescence Molecular Imaging: A Review and Analysis

  2011cited by this paper
• PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference

  2011cited by this paper
• Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

  2011cited by this paper
• Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.

  2011cited by this paper
• Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.

  2011cited by this paper
• Matrix Metalloproteinase-9 is a Diagnostic Marker of Heterotopic Ossification in a Murine Model

  2011cited by this paper
• In vivo chemistry for pretargeted tumor imaging in live mice.

  2010cited by this paper
• Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

  2010cited by this paper
• Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation

  2010cited by this paper
• Unconventional Nuclides for Radiopharmaceuticals

  2010cited by this paper
• Antibody vectors for imaging.

  2010cited by this paper
• Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.

  2010cited by this paper
• Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label.

  2010cited by this paper
• NIR dyes for bioimaging applications.

  2010cited by this paper
• Real‐time identification of liver cancers by using indocyanine green fluorescent imaging

  2009cited by this paper
• Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules.

  2009cited by this paper
• Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients

  2009cited by this paper
• Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study.

  2008cited by this paper
• Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2.

  2008cited by this paper
• Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

  2008cited by this paper
• 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging

  2008cited by this paper
• Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor.

  2008cited by this paper
• Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities

  2008cited by this paper
• A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain.

  2007cited by this paper
• Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer

  2007cited by this paper
• Near-infrared sensing properties of dimethlyamino-substituted BF2-azadipyrromethenes.

  2006cited by this paper
• Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe.

  2005cited by this paper
• Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides.

  2005cited by this paper
• Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

  2004cited by this paper
• 111In-capromab pendetide: the evolution of prostate specific membrane antigen and the nuclear imaging of its 111In-labelled murine antibody in the evaluation of prostate cancer.

  2000cited by this paper
• In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

  2000cited by this paper
• Tumor targeting with a selective gelatinase inhibitor

  1999cited by this paper

• Recent Progress in Peptide-Based Fluorescent Probes Biomedical Applications: A Review

  2025cites this paper
• Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer

  2023cites this paper
• Dual-labeled anti-CEA antibody for near-infrared fluorescence and PET imaging of colorectal cancer

  2022cites this paper
• Modular Synthesis of Peptide-Based Single- and Multimodal Targeted Molecular Imaging Agents.

  2021cites this paper
• Conjugated Photosensitizers for Imaging and PDT in Cancer Research.

  2020cites this paper
• A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery

  2019cites this paper
• MULTIMODALITY SOMATOSTATIN ANALOG FOR FLUORESCENCE-GUIDED SURGERY IN CANCER

  2019cites this paper
• Multifunctional platforms for cancer theranosis

  2018cites this paper
• Recent developments in multimodality fluorescence imaging probes

  2018cites this paper
• Copper radiopharmaceuticals for theranostic applications.

  2018cites this paper
• Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting.

  2017cites this paper
• Synthesis and spectral properties of estrogen‐ and androgen‐BODIPY conjugates

  2017cites this paper
• Phthalocyanine incorporated alginate hydrogel with near infrared fluorescence for non-invasive imaging monitoring in vivo

  2017cites this paper
• Divergent Synthesis of Dihydroxanthene-Hemicyanine Fused Near-Infrared Fluorophores through the Late-Stage Amination of a Bifunctional Precursor.

  2016cites this paper
• Hybrid tracers and devices for intraoperative imaging: the future for radioguided surgery?

  2016cites this paper
• Synthesis and photophysical properties of iron-carbonyl complex–coumarin conjugates as potential bimodal IR–fluorescent probes

  2016cites this paper